Bruker (BRKR) Capital Expenditures (2010 - 2026)

Bruker's Capital Expenditures history runs 17 years deep, the most recent figure standing at $24.2 million for Q1 2026.

• Quarterly Capital Expenditures fell 6.92% year-over-year to $24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.0 million (down 25.77% YoY) and the FY2025 annual result came in at $90.8 million, down 21.25% from the prior year.
• Capital Expenditures was $24.2 million for Q1 2026 at Bruker, up from $22.6 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $57.7 million in Q3 2022 and bottomed at $17.9 million in Q2 2022.
• A 5-year average of $27.4 million and a median of $24.6 million in 2024 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures surged 253.99% — and 2023, when it sank 53.38%.
• Bruker's Capital Expenditures stood at $34.6 million in 2022, then decreased by 8.96% to $31.5 million in 2023, then gained by 16.51% to $36.7 million in 2024, then sank by 38.42% to $22.6 million in 2025, then advanced by 7.08% to $24.2 million in 2026.
• Business Quant data shows BRKR's Capital Expenditures at $24.2 million in Q1 2026, $22.6 million in Q4 2025, and $20.9 million in Q3 2025.